Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake

Published: 2025-06-26 07:45:24 ET NATR

Published on 06/26/2025 at 07:45

By Colin Kellaher

Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount.

Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84.

Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading.

Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests.

Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility.

The company said it also may buy back up to $15 million worth of the shares Fosun is selling.

Write to Colin Kellaher at [email protected]

(END) Dow Jones Newswires

06-26-25 0744ET